{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"}],"title":"A big effect - 4"},{"measurements":[{"groupId":"OG000","value":"8"}],"title":"Not at all"},{"measurements":[{"groupId":"OG000","value":"6"}],"title":"Somewhat had an effect - 3"},{"measurements":[{"groupId":"OG000","value":"13"}],"title":"A little bit - 2"}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"}],"units":"Participants"}],"description":"Patient determined decision of scalp cooling benefit will be measured by Scalp Cooling Questionnaire, a homegrown scale ranging from no benefit to substantial benefit, with higher scores representing a better outcome.","groups":[{"description":"Patients will receive Penguin cold cap: 60 minutes prior to melphalan infusion and continue for 5 hours after melphalan infusion start time, for a total of 6 hours, on Days -2 and -1.\n\nPenguin Cold Cap: Penguin cold cap: administered 60 minutes prior to melphalan infusion and continue for 5 hours after melphalan infusion start time, for a total of 6 hours, on Days -2 and -1.","id":"OG000","title":"Penguin Cold Cap"}],"paramType":"COUNT_OF_PARTICIPANTS","reportingStatus":"POSTED","timeFrame":"Day 90","title":"Patient Determined Decision of Scalp Cooling Benefit","type":"SECONDARY","unitOfMeasure":"Participants"}